Stellate Ganglion Block in Complex Regional Pain Syndrome
RecruitingNot applicableNCT07129811
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim was to investigate the effect of Stellate Ganglion Blockade, which will be applied in addition to conventional physical therapy, on pain and functionality in patients with poststroke complex regional pain syndrome.
Study details
- Official title
- The Effect of Ultrasound-Guided Stellate Ganglion Block on Pain, Functionality, and Quality of Life in Type 1 Complex Regional Pain Syndrome in Stroke Patients
- Conditions
- Stellate Ganglion Block
- Interventions
- Procedure: Stellate Ganglion Block
- Sponsor
- Ankara City Hospital Bilkent
- Start date
- 2025-01-15
- Primary completion
- 2025-10-31
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Volunteer male and female patients aged 18-75 * Diagnosed with Complex Regional Pain Syndrome according to the IASP 2012 Diagnostic Criteria * Patient's pain level must be VAS \>4 Exclusion Criteria: * Presence of existing neurological diseases other than rheumatic diseases and stroke * General impairment * Conditions that would constitute a contraindication to application, such as an open wound or sensory deficit in the application area * Presence of active infection * Presence of malignancy * Cognitive dysfunction (mini mental test result \<23)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07129811